Respondent and Practice Characteristics and CGM Prescribing (N = 570)
| Characteristic | OR (95% CI) | P Value |
|---|---|---|
| Respondent role | <.001 | |
| Physician | Ref. | |
| Resident | 0.30 (0.16-0.58) | |
| PA or NP | 0.36 (0.16-0.77) | |
| Primary setting | .13 | |
| Private practice | Ref. | |
| Academic medical center | 1.42 (0.73-2.76) | |
| FQHC/similar | 0.88 (0.50-1.53) | |
| Hospital-owned | 1.39 (0.84-2.29) | |
| Other | 1.82 (0.93-3.57) | |
| Employment | .04 | |
| Full-time or resident | Ref. | |
| Part-time | 0.55 (0.30-0.98) | |
| Time primary care, % | .03 | |
| ≥75 | Ref. | |
| <75 | 0.60 (0.37-0.96) | |
| Miles from endocrinologist | .03 | |
| ≤10 | Ref. | |
| 11-40 | 0.95 (0.58-1.53) | |
| >40 | 1.94 (1.17-3.21) |
CGM = continuous glucose monitoring; FQHC = federally qualified health center; NP = nurse practitioner; PA = physician assistant.
Note: C-statistic = 0.688. Years since training and payer mix did not meet threshold for inclusion in final model.